Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25817 | 21429633 | Eur J Med Chem | Synthesis and biological activity of novel barbituric and thiobarbituric acid derivatives against non-alcoholic fatty liver disease. | 2011 | Details |
| A25818 | 21429628 | Gastroenterol Hepatol | [Non-alcoholic fatty liver disease. How and who to screen]. | 2011 | Details |
| A25819 | 21429453 | Arab J Gastroenterol | Incidence and risk factors for non-alcoholic steatohepatitis in females treated with tamoxifen for breast cancer. | 2011 | Details |
| A25821 | 21427524 | J Endocrinol Invest | Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence? | 2011 | Details |
| A25822 | 21426695 | Zhonghua Er Ke Za Zhi | [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes]. | 2011 | Details |
| A25823 | 21425565 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Effect of xuezhlkang capsule in intervening different Chinese medical syndrome patterns of non-alcoholic fatty liver disease complicated with carotid atherosclerosis]. | 2011 | Details |
| A25825 | 21425426 | Diabetes Metab Res Rev | Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do. | 2011 | Details |
| A25826 | 21423719 | PLoS Genet | Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. | 2011 | Details |
| A25827 | 21420035 | Transl Res | MicroRNAs and liver disease. | 2011 | Details |
| A25828 | 21418886 | Zhonghua Nei Ke Za Zhi | [The clinicopathological analysis of 88 patients with abnormal liver function test of unknown etiology]. | 2011 | Details |
| A25829 | 21418702 | Ned Tijdschr Geneeskd | [No-invasive determination of liver fat with 1H-MR spectroscopy]. | 2011 | Details |
| A25830 | 21418443 | Haemophilia | The changing face of hepatitis in boys with haemophilia associated with increased prevalence of obesity. | 2011 | Details |
| A25831 | 21418302 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese. | 2011 | Details |
| A25832 | 21418268 | Clin Exp Pharmacol Physiol | Elevation of liver enzymes within the normal limits and metabolic syndrome. | 2011 | Details |
| A25833 | 21417913 | Metab Syndr Relat Disord | Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease. | 2011 | Details |
| A25834 | 21414047 | J Intern Med | Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia. | 2011 | Details |
| A25835 | 21412813 | Hepatology | Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway. | 2011 | Details |
| A25836 | 21412139 | Am J Med Sci | Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic. | 2011 | Details |
| A25837 | 21411114 | Metabolism | Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial. | 2011 | Details |
| A25838 | 21410952 | J Inflamm (Lond) | Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice. | 2011 | Details |
| A25839 | 21410800 | Int J Exp Pathol | Is rat liver affected by non-alcoholic steatosis more susceptible to the acute toxic effect of thioacetamide? | 2011 | Details |
| A25841 | 21407274 | Nefrologia | Management of HCV infection in chronic kidney disease. | 2011 | Details |
| A25842 | 21403438 | Gan To Kagaku Ryoho | [Helicobacter pylori infection and liver diseases]. | 2011 | Details |
| A25843 | 21403434 | Tohoku J Exp Med | Elevated peripheral blood monocyte fraction in nonalcoholic fatty liver disease. | 2011 | Details |
| A25844 | 21401898 | J Dig Dis | Relationship between nonalcoholic fatty liver disease and metabolic syndrome. | 2011 | Details |
| A25845 | 21401612 | J Pharm Pharmacol | Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis. | 2011 | Details |
| A25846 | 21401320 | Arch Physiol Biochem | IRS2 and PTP1B: Two opposite modulators of hepatic insulin signalling. | 2011 | Details |
| A25847 | 21275475 | Altern Lab Anim | Mind the gap. | 2010 | Details |
| A25849 | 21397104 | Psychosomatics | Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. | 2011 | Details |
| A25850 | 21395631 | Aliment Pharmacol Ther | Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease. | 2011 | Details |
| A25851 | 21394307 | J Korean Med Sci | The relationship between normal serum uric acid and nonalcoholic fatty liver disease. | 2011 | Details |
| A25852 | 21393105 | Asia Pac J Clin Nutr | Associations between combinations of body mass index plus non-alcoholic fatty liver disease and diabetes mellitus among Korean adults. | 2011 | Details |
| A25853 | 21390143 | World J Gastroenterol | Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children? | 2011 | Details |
| A25854 | 21389796 | Eur J Gastroenterol Hepatol | Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis. | 2010 | Details |
| A25855 | 21388346 | Curr Vasc Pharmacol | Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk? | 2011 | Details |
| A25857 | 21386135 | Aging (Albany NY) | Reduced mitochondrial function in obesity-associated fatty liver: SIRT3 takes on the fat. | 2011 | Details |
| A25858 | 21383997 | Acta Biochim Pol | Retinol binding protein-4 as a serum biomarker of intrahepatic lipid content in obese children--preliminary report. | 2011 | Details |
| A25859 | 21382273 | J Biol Regul Homeost Agents | Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25860 | 21382219 | Br J Nutr | Neonatal exposure to genistein ameliorates high-fat diet-induced non-alcoholic steatohepatitis in rats. | 2011 | Details |
| A25861 | 21382165 | Liver Int | A novel and comprehensive mouse model of human non-alcoholic steatohepatitis with the full range of dysmetabolic and histological abnormalities induced by gold thioglucose and a high-fat diet. | 2011 | Details |
| A25862 | 21382157 | Liver Int | Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease. | 2011 | Details |
| A25864 | 21381068 | Hepatology | Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. | 2011 | Details |
| A25865 | 21378763 | Am J Gastroenterol | Editorial: Exercise for NAFLD: does intensity matter? | 2011 | Details |
| A25866 | 21378565 | Curr Opin Lipidol | Lipidomics is providing new insight into the metabolic syndrome and its sequelae. | 2011 | Details |
| A25867 | 21376261 | Arch Med Res | Circulating levels of vascular endothelial growth factor A and its soluble receptor in patients with biopsy-proven nonalcoholic fatty liver disease. | 2011 | Details |
| A25868 | 21374988 | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | [Influence of genipin and vitamin E on UCP2 and other correlation factors in non-alcoholic fatty liver disease]. | 2010 | Details |
| A25870 | 21374659 | Hepatology | Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. | 2011 | Details |
| A25871 | 21373917 | Internist (Berl) | [Nonalcoholic steatohepatitis. Predictor and consequence of diabetes]. | 2011 | Details |
| A25872 | 21372165 | Am J Physiol Gastrointest Liver Physiol | Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats. | 2011 | Details |
| A25873 | 21367948 | Am J Clin Nutr | Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. | 2011 | Details |
| A25875 | 21364286 | J Clin Invest | Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2. | 2011 | Details |
| A25876 | 21364120 | Am J Physiol Endocrinol Metab | Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice. | 2011 | Details |
| A25878 | 21360720 | Hepatology | Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. | 2011 | Details |
| A25879 | 21360101 | Clin Rheumatol | Familial Mediterranean fever: an association with non-alcoholic fatty liver disease. | 2011 | Details |
| A25880 | 21359922 | Chin J Integr Med | Effect of berberine on expressions of uncoupling protein-2 mRNA and protein in hepatic tissue of non-alcoholic fatty liver disease in rats. | 2011 | Details |
| A25881 | 21356259 | J Hepatol | Insulin resistance and liver microcirculation in a rat model of early NAFLD. | 2011 | Details |
| A25882 | 21356258 | J Hepatol | Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome. | 2011 | Details |
| A25883 | 21355790 | Ann Med | Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment. | 2011 | Details |
| A25884 | 21354232 | J Hepatol | Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. | 2011 | Details |
| A25885 | 21354231 | J Hepatol | Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2011 | Details |
| A25886 | 21353887 | Vitam Horm | Activin A in nonalcoholic fatty liver disease. | 2011 | Details |
| A25887 | 21352073 | Expert Opin Emerg Drugs | Treatment of non-alcoholic fatty liver disease with focus on emerging drugs. | 2011 | Details |
| A25888 | 21351214 | Inflamm Bowel Dis | Changing shape of disease: nonalcoholic fatty liver disease in Crohn's disease-a case series and review of the literature. | 2011 | Details |
| A25889 | 21350309 | J Pharmacol Sci | Novel findings for the development of drug therapy for various liver diseases: Liver microsomal triglyceride transfer protein activator may be a possible therapeutic agent in non-alcoholic steatohepatitis. | 2011 | Details |
| A25890 | 21350190 | Am J Physiol Gastrointest Liver Physiol | Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model. | 2011 | Details |
| A25891 | 21350183 | Am J Physiol Gastrointest Liver Physiol | Obesity, diabetes mellitus, and liver fibrosis. | 2011 | Details |
| A25892 | 21348922 | Obes Rev | Cardiovascular benefits of bariatric surgery in morbidly obese patients. | 2011 | Details |
| A25894 | 21348181 | G Ital Cardiol (Rome) | [Non-alcoholic fatty liver disease: a new challenge for cardiologists]. | 2010 | Details |
| A25896 | 21346716 | Eur J Clin Nutr | A case-control study on nutritional risk factors in non-alcoholic fatty liver disease in Indian population. | 2011 | Details |
| A25897 | 21346097 | J Nutr | PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver. | 2011 | Details |
| A25898 | 21345221 | Diabetol Metab Syndr | New clinical score to diagnose nonalcoholic steatohepatitis in obese patients. | 2011 | Details |
| A25899 | 21343633 | J Lipid Res | Anthocyanin inhibits high glucose-induced hepatic mtGPAT1 activation and prevents fatty acid synthesis through PKCζ. | 2011 | Details |
| A25900 | 21342625 | Zhongguo Dang Dai Er Ke Za Zhi | [The prevalence of type 2 diabetes mellitus and prediabetes in children]. | 2011 | Details |
| A25902 | 21340530 | J Gastroenterol | Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: a pilot study. | 2011 | Details |
| A25903 | 21339799 | PLoS One | Bioinformatics-driven identification and examination of candidate genes for non-alcoholic fatty liver disease. | 2011 | Details |
| A25904 | 21339204 | Gut | High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. | 2011 | Details |
| A25905 | 21339203 | Gut | The role of apolipoprotein A5 in non-alcoholic fatty liver disease. | 2011 | Details |
| A25906 | 21338989 | Atherosclerosis | Olmesartan severely weakened the development of NASH in an animal model of hypercholesterolemia. | 2011 | Details |
| A25908 | 21336428 | Nutr Hosp | Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients. | 2011 | Details |
| A25909 | 21336425 | Nutr Hosp | Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents? | 2011 | Details |
| A25910 | 21335212 | Transplant Proc | Metabolic syndrome in transplant patients: an academic or a health burden? | 2011 | Details |
| A25911 | 21334394 | J Hepatol | Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease. | 2011 | Details |
| A25912 | 21333494 | Nutrition | Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis. | 2011 | Details |
| A25913 | 21332546 | J Gastroenterol Hepatol | Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population? | 2011 | Details |
| A25915 | 21331995 | Turk J Gastroenterol | Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome. | 2010 | Details |
| A25916 | 21331443 | Int J Mol Med | Association between lipid accumulation and the cannabinoid system in Huh7 cells expressing HCV genes. | 2011 | Details |
| A25917 | 21331294 | J Obes | Suspected nonalcoholic Fatty liver disease is not associated with vitamin d status in adolescents after adjustment for obesity. | 2011 | Details |
| A25918 | 21328622 | Biofactors | Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease. | 2010 | Details |
| A25919 | 21327921 | Dig Dis Sci | Correlation analysis between gene expression profile of rat liver tissues and high-fat emulsion-induced nonalcoholic fatty liver. | 2011 | Details |
| A25920 | 21327395 | Cell Tissue Res | Telmisartan improves nonalcoholic steatohepatitis in medaka (Oryzias latipes) by reducing macrophage infiltration and fat accumulation. | 2011 | Details |
| A25921 | 21325464 | J Clin Endocrinol Metab | Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction. | 2011 | Details |
| A25922 | 21325336 | Acta Biochim Biophys Sin (Shanghai) | PGC-1 coactivators in the control of energy metabolism. | 2011 | Details |
| A25923 | 21324757 | Dig Liver Dis | High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis. | 2011 | Details |
| A25924 | 21320639 | Clin Gastroenterol Hepatol | Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. | 2011 | Details |
| A25925 | 21320636 | Int Immunopharmacol | Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms. | 2011 | Details |
| A25926 | 21319202 | Hepatology | Nuclear receptors in liver disease. | 2011 | Details |
| A25927 | 21319198 | Hepatology | Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. | 2011 | Details |
| A25928 | 21318585 | Dig Dis Sci | Non-contrasted computed tomography for the accurate measurement of liver steatosis in obese patients. | 2011 | Details |
| A25929 | 21317853 | G Ital Dermatol Venereol | Psoriasis: comorbidities and associations. | 2011 | Details |
| A25931 | 21308157 | Sao Paulo Med J | Clinical characteristics associated with hepatic steatosis on ultrasonography in patients with elevated alanine aminotransferase. | 2010 | Details |